Used in research as a key intermediate for developing antiparasitic agents, particularly in the synthesis of compounds active against protozoan infections. Shows potential in medicinal chemistry for targeting kinetoplastid parasites, including those responsible for diseases like Chagas disease and leishmaniasis. Its structure supports binding to specific enzyme sites in pathogens, making it valuable in designing selective inhibitors. Also employed in structure-activity relationship (SAR) studies to optimize bioavailability and potency in new drug candidates.